BRAF V600E immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer.
Federica GrilloMichele PaudiceSimona PigozziMaria DonoSonia LastraioliMarialuisa LugaresiSilvia BozzanoCamilla TognoniMurad AliStefania ScialleroAlberto PucciniAngelo Paolo Dei TosLuca MastracciPublished in: Histopathology (2024)
IHC can be used as a reliable surrogate of molecular testing after stringent in-house validation.